CANNAPHARMARX, INC. (CPMD)

Import this data to Google Sheets with:

=jivedata("CPMD","financials")

Full statements spill as a table. For one cell: =jivedata("CPMD","Revenue") or =jivedata("CPMD","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

CANNAPHARMARX, INC.

CPMD • CIK 0001081938

(in thousands, except per share data)	FY 2022	FY 2024	FY 2025	TTM
Revenues	$0	$820.137	$1,362.163	$1,698.916
Cost of Goods and Services Sold	—	$3,755.064	$3,447.071	$3,207.906
Gross Profit	—	$-2,934.927	$-2,084.908	$-1,508.99
Other than Temporary Impairment Losses, Investments	—	—	$4,518.127	$4,518.127
Other Expenses	—	—	$1,930	$0
Other Nonoperating Income (Expense)	—	—	$-7,783.684	$-7,470.353
Net Income (Loss) Attributable to Parent	$-8,531.02	$-9,905.789	$-11,131.448	$-11,318.459
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax	$612.335	$591.243	$-612.297	$632.419
Comprehensive Income (Loss), Net of Tax, Attributable to Parent	$-7,918.685	$-9,314.546	$-11,743.745	$-10,686.04
Weighted Average Number of Shares Outstanding, Diluted	211,044,357	625,276,406	662,501,405	676,171,360
General and Administrative Expense	$2,226.668	$116.64	$489.641	$493.601
Legal Fees	—	—	$0	$0
Professional Fees	$506.833	$435.511	$469.69	$444.761
Royalty Expense	—	—	$303.525	$443.021
Operating Expenses	$5,211.809	$671.33	$1,262.856	$1,381.383
Operating Income (Loss)	$-5,211.809	$-3,606.257	$-3,347.764	$-2,890.373
Derivative, Gain (Loss) on Derivative, Net	$-501.374	$-3,449.789	$-850.152	$-2,244.125
Foreign Currency Transaction Gain (Loss), before Tax	—	—	$66.252	$-107.16
Interest Expense	$2,290.319	$2,264.095	$1,958.785	$1,510.379
Gain (Loss) on Extinguishment of Debt	$-929.912	$-690.712	$0	$0

(in thousands, except per share data)	FY 2022	FY 2024	FY 2025	TTM
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$2.317	$2.156	$1.804	$0.555
Accounts Receivable, after Allowance for Credit Loss, Current	—	—	$164.43	$6.811
Inventory, Net	—	$996.25	$1,115.322	$1,306.302
Assets, Current	$100.014	$1,018.86	$1,311.388	$1,333.012
Property, Plant and Equipment, Net	$107.78	$137.237	$127.029	$200.461
Operating Lease, Right-of-Use Asset	—	$5,161.473	$5,579.987	$5,358.469
Investments	$78.76	$4,518.127	$0	$0
Assets	$5,414.176	$10,835.697	$7,018.404	$6,891.942
Accounts Payable and Accrued Liabilities, Current	$7,224.872	$11,771.636	$10,059.415	$5,752.511
Interest Payable, Current	$151.925	$56.298	$1,720.278	$2,193.967
Deferred Revenue, Current	—	—	$260.561	$36.242
Notes Payable, Current	$7,715.858	—	$482.661	$423.345
Convertible Notes Payable, Current	—	—	$1,017.004	$1,017.004
Derivative Liability, Current	$1,008.868	$1,159.324	$2,009.476	$2,808.176
Accrued Royalties, Current	—	—	$305.492	$483.554
Operating Lease, Liability, Current	—	—	$1,000.479	$964.994
Liabilities, Current	$17,165.154	$25,752.496	$31,589.958	$32,569.584
Operating Lease, Liability, Noncurrent	—	—	$5,033.601	$4,817.775
Liabilities	$22,758.632	$30,645.334	$37,172.133	$37,722.503
Common Stock, Value, Issued	$27.412	$66.25	$66.25	$70.869
Common Stock, Value, Subscriptions	—	$1,827.005	$0.623	$0.623
Additional Paid in Capital	$74,523.642	$80,122.59	$81,520.643	$82,547.535
Retained Earnings (Accumulated Deficit)	$-94,695.339	$-101,184.142	$-112,315.59	$-114,606.653
Accumulated Other Comprehensive Income (Loss), Net of Tax	$240.427	$555.626	$-56.671	$527.649
Stockholders' Equity Attributable to Parent	$-17,344.455	$-19,809.637	$-30,153.729	$-30,830.561
Common Stock, Shares Authorized	5,000,000,000	5,000,000,000	5,000,000,000	5,000,000,000
Common Stock, Shares, Issued	274,124,622	662,501,405	662,501,405	708,689,905
Treasury Stock, Common, Shares	133,200	6,230,761	6,230,761	6,230,761
Preferred Stock, Shares Authorized	—	—	3,200,000	3,200,000
Preferred Stock, Shares Outstanding	—	—	629,416	629,416

(in thousands, except per share data)	FY 2022	FY 2024	FY 2025	TTM
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	—	$-9,905.789	$-11,131.448	$-10,822.875
Other than Temporary Impairment Losses, Investments	—	—	$4,518.127	$4,518.127
Other Expenses	—	—	$1,930	$0
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$-25.45	—	$-0.352	$-16.42
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$2.317	$2.156	$1.804	$1.229
Inventory Write-down	—	—	$1,984.359	$1,650.63
Issuance of Stock and Warrants for Services or Claims	—	—	$142.8	$142.8
Derivative, Gain (Loss) on Derivative, Net	$-501.374	$-3,449.789	$-850.152	$-2,244.125
Foreign Currency Transaction Gain, before Tax	—	—	$66.252	$66.252
Interest Expense	$2,290.319	$2,264.095	$1,958.785	$1,510.379
Gain (Loss) on Extinguishment of Debt	$-929.912	$-690.712	$0	$0
Increase (Decrease) in Accounts Receivable	$21.593	$1.747	$1,011.297	$1,537.966
Increase (Decrease) in Inventories	—	$508.05	$1,988.051	$1,895.899
Increase (Decrease) in Royalties Payable	—	—	$303.525	$443.021
Increase (Decrease) in Other Accounts Payable and Accrued Liabilities	—	—	$2,877.89	$3,380.883
Increase (Decrease) in Deferred Revenue	—	—	$260.561	$37.42
Increase (Decrease) in Interest Payable, Net	$103.427	$-272.426	$0	$0
Net Cash Provided by (Used in) Operating Activities	$-1,448.364	$-1,697.232	$-789.102	$-112.283
Payments to Acquire Property, Plant, and Equipment	—	$0	$5.519	$60.637
Net Cash Provided by (Used in) Financing Activities	$1,404.703	$1,698.738	$-5.519	$-643.288
Proceeds from Notes Payable	—	$1,548.738	$0	$0
Proceeds from Related Party Debt	$54.739	—	$794.269	$436.321
Proceeds from Convertible Debt	$912.952	$150	$0	$0
Net Cash Provided by (Used in) Investing Activities	$-115.998	$0	$794.269	$739.151

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("CPMD","financials")

Full statements spill as a table. For one cell: =jivedata("CPMD","Revenue") or =jivedata("CPMD","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.